Wall Street saw losses after President Trump threatened to impose tariffs on various countries. The news, available only in paid plans, points to the swift impact of high-level trade announcements on financial markets and highlights ongoing economic uncertainty.

In its most recent SEC filing, Matisse Capital reported purchasing 262,527 shares in XAI Octagon Floating Rate & Alternative Income Trust, translating to an investment of roughly $1.39 million. This move underscores Matisse’s interest in floating-rate and alternative income market segments.

Root Financial Partners LLC expanded its holdings in the Vanguard FTSE All-World ex-US ETF by 67.1%, acquiring an additional 6,571 shares. According to an SEC filing, the firm now owns 16,361 shares, reflecting a notable boost in its global investment portfolio.

CenterPoint Energy is gearing up to release its fourth-quarter earnings results soon, with analysts forecasting a double-digit rise in its bottom-line figure. Observers say this positive anticipation signals broader optimism about the company’s performance.

Charles River Laboratories is on the cusp of releasing its fourth-quarter earnings report, with analysts anticipating a low–double-digit drop in year-over-year earnings. Investors and industry observers alike are watching closely to see how these figures will shape the company’s trajectory going forward.

Gold and silver soared to record highs as President Donald Trump threatened fresh tariffs on eight European countries. Investors scrambled for safe-haven assets, forcing the dollar down by 4% against major currencies.

Massachusetts Financial Services Co. MA raised its stake in Chevron Corporation by more than 30% in the third quarter, acquiring over two million new shares. The total holdings now exceed nine million shares, representing a value of more than $1.4 billion.

Nisa Investment Advisors LLC dramatically reduced its stake in Royalty Pharma PLC, selling nearly 22,000 shares in the third quarter. The move represents a 76.6% decrease, leaving Nisa with 6,689 shares of the biopharmaceutical company’s stock, valued at $236,000.

ASTS stock continues to garner attention as it heads for a possible third consecutive weekly gain. At the center of the buzz is the Trump Administration’s “Golden Dome,” an initiative designed to shield against incoming projectiles.

Shares of Atossa jumped 10% before regular trading hours, tied to the announcement of Orphan Drug Designation. This special status, granted to products for rare diseases, often provides key competitive benefits and regulatory incentives.

Several power-focused stocks, including VST, CEG, and TLN, have risen in pre-market trading amid a Trump-backed push for long-term AI power contracts. The International Energy Agency reports that global data center electricity consumption is set to grow by 15% annually from 2024 to 2030, underscoring the critical need for sustained energy infrastructure.

Bank of America has recommended five companies, including Amazon, as potential buys before earnings announcements. Its latest guidance underscores how major financial institutions view selective stock picks amid market uncertainty.

Evergreen Capital Management LLC increased its stake in the iShares 0-3 Month Treasury Bond ETF by 39.0% in the third quarter. The firm purchased an additional 80,610 shares, bringing its total holdings to 287,551 shares. Observers note this move as a noteworthy signal of investor confidence in short-term U.S. treasuries.

Rosen Law Firm has urged Tandem Diabetes Care (TNDM) investors to explore possible securities class action claims. While key details remain limited, the announcement underscores the firm’s invitation to shareholders for more information on a potential investigation.

Country Trust Bank is expanding its holdings in UnitedHealth Group, increasing its stake by 10.6% this quarter. According to the latest SEC filing, the bank added nearly 12,000 additional shares, reflecting ongoing institutional interest in the healthcare conglomerate.

Some of the world’s biggest memory makers are enjoying a market rally, driven by surging demand for artificial intelligence. As SK Hynix Inc. and Samsung Electronics log double-digit gains, industry observers are watching how smaller chip players – particularly penny stocks – could follow suit.

After suffering a 26% decline in 2025, Block’s stock has attracted the attention of investors eager for a clearer outlook. Will 2026 offer renewed promise or more hurdles ahead?

In its fourth-quarter 2025 investor letter, L1 Capital International underlines its steadfast focus on high-quality, cashflow-driven investments. The firm singles out Uber as a “battleground” stock, illustrating the ongoing debate among investors over the ride-hailing giant’s long-term prospects.

EUDA Health Holdings Limited (NASDAQ: EUDA), a Singapore-based healthcare firm specializing in non-invasive treatments, recently announced a second amendment to its warrant agreement with Streeterville Capital, LLC. The move underscores the company’s ongoing commitment to expanding its presence in Singapore, Malaysia, and China.

Two apparel giants, Levi Strauss and VF Corporation, just released financial results that reveal starkly different fortunes. Levi has posted eight consecutive strong quarters, while VF faces long-term challenges, including a reported 74% decline over five years.

The Dow Jones Industrial Average has trailed the Nasdaq for eight out of the past ten years. Yet a bold new prediction suggests that in 2026, the Dow may finally outperform both the Nasdaq and the S&P 500, drawing renewed interest to high-quality value stocks.